v3.26.3
Consolidated Statements of Changes in Shareholders' Equity - CAD ($)
Common Shares
Reserves
Deficit
Total
Balance balance at Dec. 31, 2023 $ 61,852,725 $ 15,041,618 $ (74,286,263) $ 2,608,080
Beginning balance (in shares) at Dec. 31, 2023 59,606,399     59,606,399
Common share financings, net (Note 17) $ 19,912,608 1,468,838   $ 21,381,446
Common share financings, net (Note 17 (in shares) 9,792,250      
Broker warrants (Note 17) $ (138,603) 138,603    
Warrant exercise (Note 18) $ 157,500 (18,250)   $ 139,250
Warrant exercise (Note 18) (in shares) 47,500     47,500
Option exercises (Note 18) $ 2,131,881 (856,540)   $ 1,275,341
Option exercises (Note 18) (in shares) 887,000     887,000
Stock-based compensation (Note 18)   4,529,991   $ 4,529,991
Loss and comprehensive loss     (23,664,711) (23,664,711)
Balance ending at Dec. 31, 2024 $ 83,916,111 20,304,260 (97,950,974) $ 6,269,397
Balance ending (in shares) at Dec. 31, 2024 70,333,149     70,333,149
Common share financings, net (Note 17) $ 11,653,658     $ 11,653,658
Common share financings, net (Note 17 (in shares) 5,735,374      
Warrant exercise (Note 18) $ 3,714,675 (322,058)   $ 3,392,617
Warrant exercise (Note 18) (in shares) 1,146,734     1,146,734
Warrant amendment (Note 16)   20,710,982   $ 20,710,982
Option exercises (Note 18) $ 7,621,402 (3,141,032)   $ 4,480,370
Option exercises (Note 18) (in shares) 2,434,000     2,434,000
Stock-based compensation (Note 18)   3,603,619   $ 3,603,619
Loss and comprehensive loss     (44,214,333) (44,214,333)
Balance ending at Dec. 31, 2025 $ 106,905,846 $ 41,155,771 $ (142,165,307) $ 5,896,310
Balance ending (in shares) at Dec. 31, 2025 79,649,257     79,649,257